Immune Tolerance: from Gene Expression to Drug Discovery

Immune Tolerance: from Gene Expression to Drug Discovery

Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale) Immune Tolerance and

Therapy Therapy to reverse breakdown of self tolerance in autoimmune diseases Tolerance induction rather than nonspecific immunosuppression to avoid rejection of transplanted organs Reversal of acquired tolerance to tumour antigens and latent viral infections

Why Start from Gene Expression? What are the approaches to find new therapeutics: Random screening of chemical libraries in a surrogate assay (eg. suppression of antigen specific proliferation in vitro). Look for monoclonal antibodies that modulate a function (eg. same assay). Targeted chemical design/antibodies against specific protein structures. But:

How to identify the most relevant/specific target proteins on possibly rare cells? Ideally we want targets expressed ONLY on target cells to avoid potential toxicity against other tissues. An answer: Look for genes that are specifically expressed in the functional cell type of interest in our example, Th1 but NOT T regulatory (Treg) cells.

Methods for Analysing Gene Expression Analysis of known genes (RT-PCR/Antibodies/Protein Gels): There are >1000 interesting immunological genes and probably many more important but unidentified genes. How to choose? Differential Display and Gene Cloning: Clones genes over-expressed in one cell compared to one other, but these may be shared with other cells and you dont know what you are working with until

you have it cloned and sequenced. How to choose? Gene Chips/Arrays Can identify patterns of expression from many (10,000+) genes and multiple samples. Genes must already have been cloned (<1/3 of genome?), it is quick, but not very sensitive (or reliable?), and currently expensive. SAGE (Serial Analysis of Gene Expression)

Can identify almost the entire pattern of gene expression (the transcriptome) with no a priori knowledge of the gene sequences. Multiple samples are directly comparable as a database. Sensitivity depends on the number of tags sequenced: this can be labour intensive. CD4+ T cell clones/lines against DBY-Ek male antigen Clone

Source R2.2 A1(M)xRAG-1-/(graft primed) R2.4

A1(M)xRAG-1-/(graft primed) Tr1D1 A1(M)xRAG-1-/- IL-10 (nave) (CD3 cloned)

A1MP A1(M) nave SKA line Polarised in Type

Cytokines IL-2 Th1 IFN-

IL-4 Th2 IL-4, IL-10 Tr1/Treg

IL-10 (IL-4) Treg IL-10 (IL-4) Tskin/Treg

IL-10 Anti-CTLA4 DBY-Ek peptide A1(M) + male DBY-Ek peptide skin graft CD4+ sorted IELs

SAGE details AE = Nla-III TE = BsmF1 Automated DNA Sequencing Machine

Analysis of SAGE data Use SAGEv3.01 software (Velculescu et al) to extract numbers of tags from raw sequence files. Use Access to link tags to known genes, Unigene clusters, and ESTs (from NCBI reliable tag list). Use Excel to manipulate data tables and calculate statistics (custom written function for Beysian stats). Use custom written cluster analysis and

presentation program (running on Acorn RISC-PC). DC cluster T cell clone cluster Spleen CD4 cell cluster Clustered Expression Chart

of approx. 300 known genes (CD antigens, cytokines and receptors) A close up of a Treg cluster of known genes

Real Time PCR Machine HPRT TM4 HPRT

TM4 Th1 Treg Th1 Treg

Quantitative RT-PCR from rejecting, syngeneic and tolerant skin grafts Ratio of tolerant to rejecting skin graft expression 14.8** 624** 32.6** 2.8* 0.14 0.5

3.4* 0.6 9.9 1.1

0.7 0.3 Normalized mRNA expression 1.E+06 1.E+05


Fluorescence Activated Cell Scanner Tr1D1 A1MP Tskin Th2

Th1 Chandra/Ly116 -> Live cells (7AAD neg) Permeabilized

Chandra/Ly116 -> Peptide inhibition CD25-

CD4+CD25+ Chandra/Ly116 -> CD25 -> CD103 -> CD4 ->

Th1 (R2.2) CD103 -> Treg(Tr1D1) CD103 ->

Chandra/Ly116 -> Th2 (R2.4) CD103 -> Tskin(SkA) CD103 ->

The Therapeutic Antibody Centre Humanized monoclonal antibodies against cell surface molecules expressed by effector but not regulatory T cells Monoclonal Antibody

Production Bioreactor Schematic Hollow Fibre Bioreactor for Antibody Production Therapeutic antibody purification

Clinical Trials of Therapeutic Antibody For more information see the TIG Web site: Or go to the Pathology Web site: And click on Herman Waldmann

Recently Viewed Presentations

  • AC Update

    AC Update

    This affirms that all children and young people, and their communities, have particular strengths and resources that can be nurtured to improve their own and others' health, wellbeing, movement competence and participation in physical activity. Historically….the educative approach was based...
  • TCP/IP Tools -

    TCP/IP Tools -

    Displays NetBIOS over TCP/IP (NetBT) protocol statistics for local and remote computers, NetBIOS name tables for both the local computer and remote computers, and the NetBIOS name cache NetBIOS was developed in the 1980s to allow applications to communicate over...
  • Let&#x27;s spell words ending -tion

    Let's spell words ending -tion

    Let's spell words ending -tion-tion - tion Sta tion Station I went to the train station. - tion Va ca tion Vacation We are going on vacation. -tion Cre a tion Creation God was at the beginning of creation. -...
  • Welcome Aiming High and Succeeding in Year 9:

    Welcome Aiming High and Succeeding in Year 9:

    The Labour Force Survey showed that in 2012 85% of people with a degree were in work, 75% of people with an A Level or equivalent were in work, 66% of people with GCSEs were in work, but only 42%...
  • Semiconductor detectors - University of Glasgow

    Semiconductor detectors - University of Glasgow

    Semiconductor detectors An introduction to semiconductor detector physics as applied to particle physics Contents 4 lectures - can't cover much of a huge field Introduction Fundamentals of operation The micro-strip detector Radiation hardness issues Lecture 1 - Introduction What do...
  • Treatment of Crypto Assets in Macroeconomic Statistics

    Treatment of Crypto Assets in Macroeconomic Statistics

    Crypto assets did not exist when the latest revision of the macroeconomic statistical manuals took place. Except a reference in the Monetary and Financial Statistics Manual and Compilation Guide (MFSMCG) to clarify that crypto assets lit Bitcoin are nonfinancial assets.
  • What is Programming?

    What is Programming?

    Programming is . modeling. describe salient (relevant) properties and behaviors of a system of components (objects) Programming is . abstraction. identify important features without getting lost in detail. Programming is . concrete. must provide detailed instructions to complete task. Programming...
  • Memory Systems - Assumption University

    Memory Systems - Assumption University

    For example, 0x347A0000 OR 0x000072FC = 0x347A72FC, combination of the two values. Dr. Anilkumar K.G * Arithmetic/Logical Instructions Logical operations can also operate on immediates. These I-type instructions are andi, ori, and xori. nori is not provided, because the same...